The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.
about
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic ReviewSafety of tenofovir during pregnancy for the mother and fetus: a systematic review.Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics.Tenofovir rescue therapy in pregnant females with chronic hepatitis BPhysiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya.Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.Pharmacokinetics of tenofovir during pregnancy and postpartum.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).Antiretroviral Pharmacokinetics in Pregnant Women.Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women.Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding.Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy.Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.Long-term administration of tenofovir or emtricitabine to pregnant rats; effect on Abcb1a, Abcb1b and Abcg2 expression in the placenta and in maternal and fetal organs.Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen-positive pregnant women.Darunavir for Use in Pregnant Women with HIV.Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV.Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis
P2860
Q28109657-B28EA766-F5ED-47D7-B75F-41F434AEEA44Q34371989-878B0241-E788-49DA-A2E2-13742252961AQ34429204-007075F3-D781-42E9-883B-4994CD033D51Q34635554-96A12A0D-5954-41EF-8FA6-ED9EFC5B3E75Q35128259-A20C5047-AFED-4166-80B8-A5D3BF7A53CCQ36243626-6CC89683-554E-4319-BED1-708DED8B0F0FQ36448494-28E62F59-0B99-4ADA-A59F-B62E04E85DABQ36706781-1C54A690-FE7D-4CDE-BB49-D5EF74F2FC24Q36888597-4BE1488C-B679-43B0-A527-1F260F3F566BQ38325427-9FF53E13-0A77-49D8-A321-14363C95EA27Q38571596-CA39B9AA-C396-4B06-B265-B665316415CFQ38750453-B28F57ED-1E54-4D3B-B971-65F88DC14D67Q38828635-B8949835-BB08-45B1-BEB9-F7A724AC1A9AQ38872808-6052A486-AAFA-4B22-9897-E3AF9059B564Q38909409-56056E5C-3960-4F9C-8C8B-9982ED147DD2Q38954109-538F37AA-A14F-46FD-8F0B-6589EB3491F1Q39759988-27EFAF94-DA49-4487-AC94-113B7C078001Q40148984-9FA0023E-7AAA-4543-BADE-DBEA1B25D229Q40540669-ACC879EF-72E2-4616-9D8B-73650B5B9894Q41922010-440EF03B-518C-4796-9736-5EE16DC558F2Q47548999-EEC13944-E21D-4DA9-9326-CD6B78620248Q56910156-F7CDE97F-DBCD-44D6-A6E8-B5CB1D644F23
P2860
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The pharmacokinetics, safety a ...... HIV-1-infected pregnant women.
@en
The pharmacokinetics, safety a ...... HIV-1-infected pregnant women.
@nl
type
label
The pharmacokinetics, safety a ...... HIV-1-infected pregnant women.
@en
The pharmacokinetics, safety a ...... HIV-1-infected pregnant women.
@nl
prefLabel
The pharmacokinetics, safety a ...... HIV-1-infected pregnant women.
@en
The pharmacokinetics, safety a ...... HIV-1-infected pregnant women.
@nl
P2093
P1433
P1476
The pharmacokinetics, safety a ...... HIV-1-infected pregnant women.
@en
P2093
Andrea Gingelmaier
Angela P H Colbers
Carlo Giaquinto
Christopher Wyen
David A Hawkins
David M Burger
Graham P Taylor
Jelena Ivanovic
José Moltó
Kabamba Kabeya
P304
P356
10.1097/QAD.0B013E32835C208B
P407
P577
2013-03-01T00:00:00Z